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Background
DNA cytosine methylation in the form of 5-methylcytosine (5mC) in CpG context is an epigenetic marker that is important for regulation of gene expression. Changes in CpG methylation are implicated in many diseases, and proper methylation patterns are required for normal development [1] . Large scale studies such as ENCODE [2] and the Human Epigenomics Roadmap [3] have performed extensive profiling of 5mC in various cell lines and tissues revealing a rich and dynamic landscape of 5mC patterns in the human genome. Given the importance of these markers to cellular development and contribution to disease, a number of approaches have been developed for detecting the methylation status of cytosines [4] , with bisulfite sequencing (BS-seq) being widely used to provide single-base quantitative measurement of 5mC (and 5-hydroxymethylcytosine, 5hmC). Bisulfite sequencing refers to massively parallel sequencing after chemical deamination of cytosines (C) to uracils (U), followed by polymerase chain reaction (PCR). The deamination of cytosines is accomplished by the use of sodium bisulfite, and this pretreatment preserves both the methyl modification in 5mC and the 5-hydroxymethyl modification in 5hmC [5] . The benchmark in methylome coverage is whole genome bisulfite sequencing (WGBS), which at 30X sequencing coverage, accounts for ~94% of all cytosines in the genome with 99.8% of them being CpG loci [6] . However, different WGBS library preparation protocols can bias region coverage. Since no method completely covers the methylome, and biologically relevant CpGs have been identified in known genomic features [1, 7] , developing focused assays considering these features is in demand with the caveat that these approaches will leave gaps in the methylome potentially excluding important CpGs.
There are several methods for acquiring DNA methylation levels and we investigated the characteristics of three currently widely used platforms: i) enrichment by enzymatic digestion 3 (MspI) enhanced reduced representation bisulfite sequencing (ERRBS) [8] , ii) capture based Agilent SureSelect Methyl-Seq (SSMethylSeq), and iii) capture based Roche NimbleGen SeqCap Epi CpGiant (CpGiant).
In this paper we present an analysis of the methylation pattern of the human lung fibroblast IMR-90 cell line profiled by each of the platform protocols, using two technical replicate libraries for ERRBS, and two libraries each for SSMethylSeq and CpGiant, one at the manufacturer's suggested concentration and one at a reduced concentration (Table 1 and Additional file 1: Table   S1 ). The capture libraries differ only in concentration of input material and are treated effectively as technical replicates. All libraries were sequenced to equivalent depth and compared to a library made using WGBS.
Materials and Methods
Cell growth and DNA preparation Valencia, CA). DNA was resuspended in TE, quantified using fluorometric quantification (Qubit 2.0 ThermoFisher Scientific Waltham, MA) and quality was assessed by running on a 1% agarose gel.
ERRBS (digestion-based enhanced reduced representation bisulfite sequencing)
tailing, and adapter ligation with Illumina TruSeq adapters, the region corresponding to 84-334bp was size-selected as two fractions. Each fraction was subjected to overnight bisulfite conversion (55 cycles of 95°C for 30 sec, 50°C for 15 min) using EZ DNA methylation kit (Cat # D5002, Zymo Research, Irvine CA). Purified bisulfite converted DNA was PCR amplified using TruSeq primers (Illumina Inc. San Diego, CA) for 18 cycles of denaturing, annealing and extension/elongation steps using Roche FastStart (cat # 03 553 361 001) -94°C for 20 secs, 65°C for 30 secs, 72°C for 1 min, followed by 72°C for 3 min. The resulting libraries were normalized to 2nM and pooled at the same molar ratio. Samples were clustered at 6.5pM on a V3 paired-end read flow cell and sequenced for 100 cycles on an Illumina HiSeq 2500.
Agilent SureSelect Methyl-Seq (SSMethylSeq)
Two libraries were made according to the company's specifications using 3ug and 1ug of DNA.
DNA was sonicated using a Covaris S220 sonicator (Covaris, Woburn, MA) to obtain products of 150-200bp. DNA was then end-repaired, A-tailed and ligated with methylated adapters to create pre-capture DNA libraries. DNA Libraries were then hybridized to the RNA SureSelect Human methyl-seq capture library at 65°C for 16 hrs. Hybridized products were purified by capture with Strepdavin beads and then subjected to bisulfite conversion (64°C for 2.5hr) using the Zymo EZ DNA Gold kit (Cat # D5005, Zymo Research, Irvine CA). The bisulfite treated libraries were PCR amplified for 8 cycles with Agilent Taq to get the required amount of DNA library and then indexed by another 6 cycles of PCR amplification to create the final libraries. Libraries were clustered at 11pM on a V3 paired-end read flow cell and sequenced for 100 cycles on an Illumina HiSeq 2500.
obtain products of 180-220bp. DNA was then end-repaired, A-tailed and ligated with methylated 
Whole Genome Bisulfite Sequencing (WGBS)
Briefly, 100 ng of DNA were bisulfite converted using EZ DNA Methylation-Gold Kit (cat # D5005, 
Computational analysis
Illumina's CASAVA 1.8.2 was used to generate fastq files from basecalls. Raw fastq reads were processed by a custom pipeline that consists of: 1) filtering raw fastq reads for pass filter reads, 2) trimming adapter sequence by FLEXBAR [9] , 3) genomic alignments performed using Bismark [10] and Bowtie [11] to reference human genome hg19, and 4) methylation calling by a custom PERL script [8] . Custom analysis scripts were written in R (version 3.3.0 [12] 
Results

Region coverage
Targeted capture techniques (SSMethylSeq and CpGiant) have a designed set of genomic regions and therefore, a predicted set of CpGs covered. SSMethylSeq is specifically designed to capture CpGs from a single DNA strand, where the other platform capture CpGs from both DNA strands.
The ERRBS protocol is considered targeted to the extent that the restriction digest produces consistent genomic fragments, sizes from 84-334bp are isolated during the library preparation gel extraction step. Note that since the DNA for WGBS is randomly sheared and coverage depends upon sequencing depth, there are no predicted regions per se and consequently WGBS is 
Description of analysis
Even though the platforms are different, the data are all bisulfite sequencing data, thus the procedure for processing the data is the same. First we evaluated sequencing and alignment consistency. Next we compared strand symmetry of methylation values, since the SSMethylSeq platform is designed to cover predominantly one strand. Then we evaluated several measures to quantify properties of each platform relating to the target regions that are covered, methylation levels of cytosines in CpG context and coverage of genomic regions. Target region analysis includes the number of CpGs covered, the fraction of target regions covered, the coverage of target region CpGs, the overlap of CpGs across all platforms, and the concordance of methylation levels of overlapping CpGs. Similarly, genomic region evaluation is comprised of the number and fraction of annotated CpGs by genomic feature (i.e. CpG islands or shores -2kb flanking the islands) and by gene part (i.e. promoter, exon, intron), and the overlap, coverage, and concordance of genomic annotations. We used the median absolute deviation (MAD), a robust measure of variability insensitive to outliers, to estimate the statistical dispersion in methylation level comparisons.
Sample preparation and sequencing
The general library preparation protocol for ERRBS is to digest input DNA with the methylation platform captures and measures methylation from only one DNA strand. Second, in CpGiant's methodology bisulfite conversion is performed before hybridization to oligonucleotides whereas in SSMethylSeq bisulfite conversion is performed prior to genomic capture. Hence, CpGiant's probe design must capture the various combinations of DNA sequences that can result from bisulfite conversion. In contrast to the targeted approaches WGBS is unbiased and relies on bisulfite breakage of genomic DNA. All libraries were made from human lung fibroblast IMR90 cell line DNA and prepared as described in the materials and methods with prominent differences outlined in Table 1 . 
Sequencing and alignment characteristics
Generally, all platforms produced similar sequencing results with no noticeable bias or reduced quality scores. The number of clusters and number of pass filter reads produced a typically consistent number of usable reads for all samples (254M +/-37M), see Additional file 1: Table S3 for more details.
Consistent with other bisulfite converted samples the number of uniquely mapped reads was ~ 70.8% sd=5.2% (Figure 2A ). Across all platforms, a mean of 24.2%, s= 2.2% of reads were not aligned and ambiguously mapped reads showed a larger proportion for ERRBS (~12.1%), than WGBS (4.6%), SSMethylSeq (1.4%), or CpGiant (1.4%) (Figure 2A ). These observations indicate the propensity of designed platforms to avoid repetitive regions or paralogous regions in contrast to ERRBS where no such selection is possible.
Strand methylation symmetry
Maintenance of symmetric methylation patterns across complementary CpG sites is required in order to preserve methylation patterns across cellular divisions. In principle, measuring methylation levels on one strand is sufficient to infer the cellular methylation state. Indeed, the SSMethylSeq platform is designed to capture only one strand in contrast to all other platforms that capture from both strands ( Figure 2B ). We note that this is different from measuring hemi- 
CpG-unit overlap and methylation levels concordance
Overall, the average number of common CpG-units covered by all three platforms is ~30% +/-1% Figure S3 and Table S4 ). Among inter-platform samples we observed less overlap; median number of shared CpG-units ~1.5M, median overlap 39.1%
( Figure 5 upper triangle, Additional file 1: Figure S3 and Table S4 ). Methylation levels of common CpG-unit's across all platforms are highly concordant indicating that methylation level measurements are consistent and reproducible with average MAD = 0.41 and sd = 0.25 ( Figure 5 lower triangle, Additional file 1: Figure S3 and Table S4 ). Inter-platform concordance was slightly lower than intra-platform concordance with mean MAD = 0.46 and sd = 0.27 ( Figure 5 lower triangle, Additional file 1: Figure S3 and Table S4 ). These results demonstrate that while the platforms differ in their capture approaches and bisulfite conversion kits (Table 1) 
Coverage of genomic feature regions by CpG-units
Next we were interested in what genomic features are covered by each platform and the degree of coverage. Analogous to the previous analysis, here we define a region as being one of exon, intron, promoter, CpGi, or shore, and coverage is a genomic region that contains at least one detected CpG-unit. It should be noted that the genomic feature annotations are not mutually exclusive and that some CpG-units are annotated by more than one category. Naturally, the targeted platforms focus on genomic regions known to play important roles in epigenetic regulation such as promoter regions, CpG islands, and CpG shores and ERRBS covers the same regions, but to a lesser degree ( Figure 6A ). Moreover, each platform covers similar proportions of CpG-units in particular genomic region ( Figure 6B ). Conversely, we looked at the number of CpGunits that have an annotation and observed similar trends for the three platforms with ERRBS having a larger proportion of unannotated CpG-units (~27%, Figure 6C ). Overall, no platform is significantly enriched for particular genomic region although ERRBS is slightly less represented in promoters, CpG islands and CpG shores, while having more representation of unannotated CpGunits.
Overlap of CpG-units annotated with a genomic feature
We evaluated the overlap of annotated CpG-units to determine whether any platform is enriched for a particular genomic feature (e.g. exons, introns, promoters, CpG islands and shores). Again, it should be mentioned that the genomic feature annotations are not mutually exclusive and that some CpG-units are annotated by more than one category. However, a CpG-unit is counted as annotated if it has one or more annotations. Comparing the overlap in annotations across platforms, we see a similar grouping as above with the methylation levels, intra-platform overlap is high (mean overlap 93.7% sd=2.9%), and inter-platform overlap is lower (mean 55.1% sd=15.5%) ( Figure 7 and Additional file 1: Figures S4-S9 ). Thus, we observed similar proportions of genomic region coverage across all platforms, but lower overlap of annotated CpG-units suggesting coverage of different loci within those regions.
Discussion
We performed a systematic analysis of the characteristics of three prominent platforms for reaching sufficient coverage for reliable measurement of CpG methylation by WGBS is still prohibitive. We conclude from our comparative study that capture-based approaches provide comparable results and cover more precisely their intended targets than ERRBS, which is a restriction enzyme based approach. They also provide the added flexibility of designing custom capture for surveying regions of interest. On the other hand, digestion based protocols are currently more cost effective and may be the only option for clinical samples where the amount of input DNA is limited. In the absence of any prior knowledge about the genomic regions of interest for a particular study, the choice of methylation profiling platform should be guided by cost and amount and quality of input DNA.
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